Please login to the form below

Not currently logged in

AZ’s Gabriel Baertschi joins Grünenthal as CEO

He also becomes chairman of the corporate executive board

Grunenthal Gabriel BaertschiAachen, Germany-headquartered Grünenthal has named AstraZeneca's Gabriel Baertschi as its new chief executive officer, with effect from 1 October.

He succeeds Dr Eric-Paul Pâques who was appointed to the role in 2013, and retires at the end of the year.

Baertschi moves to the independent pharmaceutical firm from AstraZeneca, where he currently serves as country president for the company's operations in Japan.

Prior to taking up this role three years ago, Baertschi was AZ's country president for Germany and has led a number of its other operations in emerging markets.

Dr Wilhelm Moll, chairman of Grüenthal's supervisory board, said: “We are delighted that Gabriel Baertschi will join Grüenthal Group as chief executive officer.

“His deep experience in growing the business and developing the organisation in major developed and emerging markets will be a great asset for Grünenthal.

“He joins us at an exciting time when our strategy of expanding our strategic partnerships in research and development in Europe as well as in Latin America are accelerating our global growth.”

Dr Moll added: “We would like to thank Prof Dr Pâques for his outstanding leadership, integrity and extraordinary personal commitment for the future of a successful Grüenthal.”

15th June 2016

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company
Solaris Health

The beauty of detail: an effective, compelling medical communications campaign requires each component to be carefully planned, expertly crafted and...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...